Dr. Abdul Aziz Al Ghethami serves as Consultant Interventional Cardiologist; Director, Adult Cardiology Fellowship Program at King Abdulaziz Cardiac Center, King Abdulaziz Medical City in Riyadh, Saudi Arabia.

Dr. Abdullah Esmaiel, MBBCh, FRCP(C) is the Head of the Cardiology Department at Mubarak Al-Kabeer Hospital. He is an Interventional and Structural Cardiologist trained at McGill University, Canada. Dr. Esmaiel is board-certified in Internal Medicine and Cardiovascular Disease by the American Board of Internal Medicine (ABIM) and the Royal College of Physicians and Surgeons of Canada, and he holds certification from the National Board of Echocardiography (NBE), USA.
He also holds a postgraduate qualification in Diabetes Care and Education from the University of Dundee, Scotland. Dr. Esmaiel has received multiple awards recognizing his clinical excellence and dedication to advancing cardiovascular patient care and medical education.

Prof. Abdullah Shehab serves as Professor of Cardiology, Vice President Gulf Intervention Society, Vice President and Head of Hypertension Working Group, Emirates Cardiac Society, Editor in Chief NEMJ at Mediclinic & Burjeel Hospital in Al Ain, United Arab Emirates.

Dr. Ahlam Atiq is a Consultant Pediatric Cardiologist at Sultan Qaboos Hospital in Salalah, Oman, dedicated to advancing subspecialized pediatric cardiac care. She laid the foundation for her career by completing her pediatric residency training through the Oman Medical Specialty Board (OMSB). Driven by a commitment to diagnostic excellence and complex congenital heart disease management, she pursued advanced international training, earning a Fellowship in Pediatric Cardiology from the Royal College of Physicians of Ireland (RCPI).
Recognizing the crucial role of advanced technology in modern cardiac care, Dr. Atiq further specialized by completing a fellowship in Canada focused on 3D cardiac imaging and cardiac Magnetic Resonance Imaging (MRI). This specialized background equips her with deep expertise in non-invasive multi-modality cardiac imaging, precise structural assessments, and the management of complex congenital heart conditions in children. Today, she combines her rigorous international background with her clinical role in Salalah, delivering advanced, high-precision pediatric cardiovascular care to her patients.

Dr. Ahmed Al Jezzeri serves as Consultant Cardiologist at King Abdulaziz Medical City in Riyadh, Saudi Arabia.

Dr. Ahmed Abdalla Emam is a Consultant Interventional Cardiologist and the Director of the CTO and Hypertension Programs at the Kuwait Heart Centre, Chest Disease Hospital, Kuwait. With over two decades of extensive clinical experience across high-volume centers.

He specializes in complex cardiac interventions.

Dr. Emam is an active researcher, international congress speaker, and editorial board member for cardiovascular journals.

Dr. Alaa Al Lawati is a Consultant Pediatric Cardiac Surgeon at the Royal Hospital’s National Heart Centre in Muscat, Oman. His specialty includes congenital cardiac surgery.

Dr. Ali Al Kindawi serves as Consultant Cardiologist at Hamad Medical Corporation in Doha, Qatar.

Dr. Amna Al Busaidi, MD, FRCPC is a dual (American & Canadian) board certified cardiologist specialized in Advanced Heart Failure, Heart Transplantation, and Mechanical Circulatory Support. She currently serves as a Consultant at the National Heart Centre, The Royal Hospital, Muscat, Oman.

Dr. Al Busaidi chairs Oman’s National Heart Transplant Committee, through which she has spearheaded the establishment and development of the country’s national heart transplantation program.

In addition to her clinical and leadership roles, she serves as Program Director of the Adult Cardiology Fellowship Program at the Oman Medical Specialty Board, leading efforts to advance postgraduate cardiology education and training.

Her work is driven by a commitment to clinical excellence, innovation, and the development of advanced cardiovascular services in Oman.

Dr. Amro Sayed, MD, PhD, MRCP, is an Interventional Cardiology Consultant and Supervisor of the Cath Lab at Salalah Heart Center. Dr. Amro's clinical and research interests include complex coronary interventions, intravascular imaging, and Transcatheter Aortic Valve Implantation (TAVI).

Atsushi Sugiura, MD, PhD, FESC is Director of the Structural Heart Program and Co-Director of the Department of Cardiology at Nagoya Heart Center, Japan, and former Oberarzt at the University Hospital Bonn, Germany. He specializes in transcatheter valve interventions, including TAVI, mitral and tricuspid TEER, and emerging valve replacement therapies. His research focuses on imaging-guided intervention, patient selection, and procedural outcomes. Dr. Sugiura has authored over 90 peer-reviewed publications and serves as faculty at major international meetings, promoting innovation and global collaboration in structural heart disease.

Professor Charbel Abi Khalil, MD, PhD, EMSc(econ), FESC, FACC, FAHA, is a Consultant Cardiologist, Professor of Genetic Medicine, Medicine, and Population Health Sciences, and Assistant Dean of International Affairs. He leads the Abi Khalil Lab, where his research focuses on cardiovascular disease, particularly the cardiovascular complications of diabetes and cardiovascular-kidney-metabolic (CKM) syndrome. His work combines clinical trials, epidemiology, genomics, and molecular research to better understand cardiovascular disease and improve patient outcomes.

Dr. Daniel Ishak is an Australian-trained Respiratory and Sleep Medicine Physician based in New South Wales, Australia. His clinical interests include asthma, COPD, sleep disorders, lung cancer, interstitial lung disease, and interventional pulmonology. Alongside his clinical practice, he contributes to research focused on improving COPD diagnosis, inhaler techniques, and non-invasive ventilation care. Dr. Ishak provides consultations in English and Arabic.

Dr. Dawn L Adamson serves as Consultant Interventional Cardiologist; Associate Medical Director at University Hospitals Coventry and Warwickshire NHS Trust in Coventry, United Kingdom.

Dr. Fahad Alhajri is a Consultant Interventional Cardiologist at Mubarak Al-Kabeer Hospital in Kuwait. He completed his medical training in the United States, earning American Board of Internal Medicine certification in Internal Medicine at the University of Virginia in Charlottesville. He subsequently moved to Boston, Massachusetts, where he completed his Cardiovascular Disease Fellowship at Tufts University–Tufts Medical Center and achieved board certification in Cardiovascular Disease. He then completed his Interventional Cardiology Fellowship at Beth Israel Lahey Health (BILH) and achieved board certification in Interventional Cardiology.
Dr. Alhajri is also board certified in Echocardiography through the National Board of Echocardiography (NBE) and in Nuclear Cardiology through the Certification Board of Nuclear Cardiology (CBNC).
He is a Fellow of several international professional societies, including the American College of Cardiology (FACC), the Society for Cardiovascular Angiography and Interventions (FSCAI), and the Gulf Heart Association (FGHA).
He is the Founder and Chair of the annual Cardiology Updates Conference in Kuwait. He actively participates in regional and international cardiology conferences as faculty and speaker and serves as a research and abstract reviewer for major scientific meetings, including the American College of Cardiology (ACC) Annual Scientific Session and EuroPCR Congress.
His clinical interests include cardiogenic shock management and intravascular imaging. He also leads a specialized referral clinic for patients with cardiac amyloidosis.

Dr. Fahad Almehmadi is a Consultant Cardiac Electrophysiologist at King Faisal Cardaic Center in Jeddah, Saudi Arabia. He is also an Assistant Professor of Medicine and the Assistant Dean of Clinical Affairs at the College of Medicine at KSAU-HS in Jeddah. He also serves as Vice President of the Saudi Heart Rhythm Society. 

MD, Cardiology, PhD in Clinical Pharmacology (Université de Lorraine, Nancy; Université Claude Bernard, Lyon, France; and Oxford MRC, UK). 

Emeritus Professor of Therapeutics at the Université de Lorraine and Past Director of the Inserm Clinical Investigation Center and of hypertension and Heart Failure Unit at CHU Nancy, France. 

As a clinical pharmacologist, he coordinated 2 major EU FP7 grants and developed expertise in biomarker and proteomic science in heart failure (HF).

As a clinical scientist, he has significantly contributed to building most of the trial-based evidence supporting foundational HF drug therapy, as well as the management of major comorbid conditions in HF. 

As a clinical trialist, he is the founder and chair of the Global CardioVascular Clinical Trialists (CVCT) Forum, a global think tank dedicated to the science of clinical trials, partnering with the US FDA.

FZ has also co-founded and operates the Transatlantic Heart Failure Biomarker Working Group, MOSAIC, a multi-organ, multispecialty trialist think tank. 

With over 1400 publications, more than 300,000 citations, and an H-index of 174, as of September 2026, he is a Highly Cited Researcher Award recipient in the field of Clinical Medicine. He chaired the Société Française d’Hypertension Artérielle (2005-2007). He received the 2014 European Society of Hypertension Paul Milliez Award, the 2017 ESC-Heart Failure Association Lifetime Achievement Award, the 2019 Eugene Braunwald Harvard Medical School scholarship, and the 2022 Heart Failure Society of America's International Honorary Fellowship Award. 

Dr. Fawad Bardooli serves as Consultant Interventional Cardiologist at Mohammed bin Khalifa bin Salman Al Khalifa Specialist Cardiac Centre in Riffa, Bahrain.

Dr. Fawaz Alenezi serves as Associate Professor of Medicine; Cardiologist at Duke University School of Medicine, Duke Health in Durham, United States of America.

Dr. Firas Al Badarin, MD, is a consultant cardiologist at the Heart and Vascular Institute at Cleveland Clinic Abu Dhabi and the Head of the Imaging Working Group of Emirates Cardiac Society.

Dr. Al Badarin trained at Henry Ford Hospital/ Wayne State University, Mayo Clinic, and University of Missouri, Kansas City/ Saint Luke's Mid America Heart Institute in USA. He also completed a Cardiovascular Outcomes Research fellowship and received a master's degree in Clinical Bioinformatics/Clinical Research Focus from the School of Medicine, Department of Health and Bioinformatics, University of Missouri, Kansas City, Kansas City, MO, USA.

During training, Dr. Al Badarin developed interest and expertise in various non-invasive imaging modalities, including PET and SPECT radionuclide cardiac imaging Cardiac CTA. He also became particularly passionate about understanding how different imaging technologies can be used to improve the efficiency of care for patients suspected to have coronary artery disease. He has published several peer-reviewed articles on how information from non-invasive imaging can be used to optimize outcomes and quality of life for patient

Professor Lip, MD, is Price-Evans Chair of Cardiovascular Medicine, at the University of Liverpool, UK.
Professor Lip has a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into international guidelines. He has proposed and validated holistic and integrated care management patient pathways for AF, with the ABC (Atrial fibrillation Better Care) pathway proposed by him recommended in global guidelines, and shown to reduce adverse outcomes in AF patients.

Professor Lip has acted as senior/section editor for major international textbooks and at senior editorial level for major international journals, including Thrombosis & Haemostasis (Editor-in-Chief, Clinical Studies); Europace (Associate Editor); and Circulation (Guest Editor).

Dr. Hector I. Michelena is a cardiologist and echocardiographer at Mayo Clinic. His clinical and research interests include heart valve and structural heart disease, aortic conditions, and cardiac imaging.

Dr. Holger Thiele serves as Medical Director, Department of Internal Medicine/Cardiology; Professor of Cardiology at Heart Center Leipzig at Leipzig University in Leipzig, Germany.

Dr. Igor E. Konstantinov is a cardiovascular surgeon at Mayo Clinic and a professor of surgery. His clinical specialties include pediatric cardiovascular surgery and transplantation, with a focus on congenital heart conditions.

Dr Jonathan Byrne is a leading interventional cardiologist who specialises in the treatment of coronary artery disease. He is an expert in the treatment of patients with angina, heart failure, heart rhythm disturbances and high blood pressure. He practises at the Cleveland Clinic, King's Private, OneWelbeck and the Sloane Hospital, all located in London. He also practises at the King's College Hospital NHS Foundation Trust, where he is the Clinical Director of Cardiovascular Services.

Dr Byrne treats patients with valvular heart disease using new treatments which do not require an operation, such as TAVI (transcatheter aortic valve implantation) and MitraClip (percutaneous treatment of the mitral valve).

He is also highly experienced in a number of imaging tests for the heart, including transoesophageal echocardiography and cardiac CT scanning.

Dr Byrne completed his undergraduate medical training at the University of Bristol, receiving his MB ChB in 1995. He then continued general professional medical training in South East England and London, where he received his MRCP in 1999. He then completed his PHD at the academic department of Cardiology at King’s College Hospital, examining molecular mechanisms underlying left ventricular hypertrophy. Dr Byrne continued his training in interventional cardiology at King’s College Hospital from 2004. He went on to become a Boston Scientific sponsored Interventional Fellow on Vancouver Island, Canada.

Since appointment as a consultant in July 2008, Dr Byrne has also been involved in the development of the structural programme at King’s College Hospital, with the use of novel percutaneous techniques to treat aortic and mitral valve disease.

He is a member of the British Cardiovascular Intervention Society, the British Cardiovascular Society, the Royal Society of Medicine (Cardiology), the British Heart Valve Association and the Medical Defence Union.

When he is not treating patients, Dr Byrne carries out research on different cardiology treatments.

Dr. Jonathan T. Neumann serves as Senior Physician, Heisenberg Professor for Internal Medicine and Cardiology, Adjunct Associate Professor at University Heart and Vascular Center Hamburg, Monash University in Hamburg, Germany.

Dr. Joseph A. Dearani is Director of Pediatric and Adult Congenital Heart Surgery at Mayo Clinic and a professor of surgery. His expertise includes congenital heart surgery, Ebstein anomaly, hypertrophic cardiomyopathy, and robotic heart surgery.

Dr. Khalid Al Najashi serves as Consultant Cardiologist at King Abdulaziz Cardiac Center, King Abdulaziz Medical City in Riyadh, Saudi Arabia.

Professor Lars Køber, MD, FESC, is Professor of Cardiology at Rigshospitalet, University of Copenhagen, Denmark, where he heads the Clinical Research Unit in the Department of Cardiology. He also leads the nationwide Capture-HFpEF project at Herlev-Gentofte Hospital. His research focuses on heart failure, cardiovascular epidemiology, and randomized clinical trials, with major contributions to international treatment guidelines. He has published approximately 1,400 scientific papers and supervised more than 50 PhD graduates. Professor Køber received the European Society of Cardiology Gold Medal in 2025 and chairs the 2026 ESC Guidelines for the management of heart failure.

Professor Mansour Sallam is a clinical cardiologist with a special interest in coronary artery disease, from prevention to non-invasive and invasive assessment and pharmacological and mechanical treatment. In the last 20 years he has performed in Egypt and Sultanate of Oman more than 7,000 coronary angiographies and angioplasties, vast majority performed via radial and ulnar approach.

He graduated from Al-Azhar University, Cairo, Egypt, received the preliminary training in Al-Azhar University hospitals in Egypt then improved the interventional skills at San Raffaele University Hospital, Milan, Italy under direct supervision of Professor Antonio Colombo and Professor Carlo Di Mario.

Dr. Mansour Sallam is currently a Professor of cardiology at Al-Azhar University, Cairo Egypt. Currently _x000B_ Sr. consultant cardiologist at Medical City for Military and Security Services (MCSS), Muscat, Oman.

Despite his clinical and teaching commitments, he undergone many research activities especially in the interventional cardiology pertaining to radial approach.

Prof Markus Schlaich (Royal Perth Hospital and University of Western Australia, Perth, AU) is a Renal Physician and an ESH accredited Hypertension Specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of hypertension. Prof Schlaich has a specific interest in treatment modalities targeting the sympathetic nervous system and has contributed to the development of renal denervation as novel therapeutic approaches to hypertension. He has authored more than 375 articles and book chapters in peer reviewed journals and has received several research prizes and awards. He serves on the Executive Committee of the High Blood Pressure Research Council of Australia and the Council of the International Society of Hypertension and is Co-Chair of the Regional Advisory Group for North Asia, South-East Asia & Oceania. He is also a founding member of the ESH Working Group on Interventional Treatment of Hypertension. He is on the Editorial Board of Hypertension and Journal of Hypertension.

Mary Laurine Perez Noquez, RMT, RDCS, is a Clinical Application Specialist at Us2.ai, specializing in echocardiography and AI-assisted cardiac imaging. A Registered Medical Technologist and Registered Diagnostic Cardiac Sonographer from the Philippines, she supports the adoption of automated echocardiographic analysis through clinical training, hands-on workshops, and software demonstrations. Her work focuses on helping healthcare professionals integrate AI into cardiac imaging workflows.

A consultant cardiologist with over a decade working in King Fahad Specialist Hospital in Dammam. My special interests are in heart failure and cardio-oncology. King Fahad Specialist Hospital is the only tertiary and quarternary cancer center in the Eastern Province of Saudi Arabia under the Ministry of Health. We have worked to establish cardio-oncology services to attend to the needs of the cancer patients and facilitate their therapies whilst mitigating the risk of cardiotoxicities.

I also function as the group Vice President of Quality at Performance at the Eastern Health Cluster dedicated to providing top-quality healthcare in the Middle East. With a strong focus on person-centric and value-based care, I aspire to improve healthcare outcomes and achieve the quadruple aim of better health, care, value, and joy at work.

I have completed my under and post graduate fellowship training under the Royal College of Surgeons in Ireland and Beaumont Hospital in Dublin. I also hold a fellowship from the Royal College of Physicians and Surgeons in Glasgow. I have an MSc in Healthcare administration from RCSI-Bahrain, along with other certifications. I am heavily involved in research and have been one of the authors of most of the heart failure guidelines in KSA over the past 7 years.

• Dr. Mohamed Salim Kabbani graduated from Damascus Medical School, Syria.
• He completed his Pediatric Residency Training at the Rush Presbyterian St Luke University, Chicago, USA, and a fellowship training in Pediatric Critical Care Medicine at the University of Florida, Gainesville, Florida, USA.
• He is a Pediatric Cardiac ICU consultant at King Abdulaziz Medical City, with a joint appointment as Professor of Pediatric Critical Care Medicine at King Saud bin Abdulaziz University for Health Sciences , Riyadh, Saudi Arabia.
• He is program director for the Pediatric Cardiac ICU Fellowship training Program in King Abdulaziz Medical City,.
• He participated as primary author or as coauthor in more than 70 peer-reviewed medical journal publications and he was invited speaker in different national and international scientific meetings.

Dr. Mohammad Abdelghani, MBBCh, MSc, MD, PhD, is an Associate Professor of Cardiology at the School of Medicine, Al-Azhar University in Cairo, Egypt, as well as a Consultant Interventional Cardiologist at Sohar Hospital in Sohar, Oman. He earned his Bachelor's degree in Medical Sciences & Surgery with excellent-with-honors from Al-Azhar University, followed by a Master's degree and MD degrees from the same University. He was awarded a PhD in Cardiology from the University of Amsterdam in the Netherlands. His clinical training includes an Interventional Cardiology Fellowship at Segeberger Kliniken in Bad Segeberg, Germany.

Dr. Abdelghani has contributed extensively to academic cardiology as the author of over 100 peer-reviewed publications and book chapters, alongside serving on editorial boards and as a regular reviewer for prominent international medical journals. He is an active professional member of the ESC and the EAPCI.

Dr. Mohammed Al Ghafri is a senior pediatric intensivist and the Head of the Pediatric Cardiac Intensive Care Unit. I also serve as Program Director of the Pediatric Intensive Care Fellowship Program at the Oman Medical Specialty Board, where I contribute to the training and professional development of future pediatric intensivists.

My clinical interests include pediatric critical care and the management of children with complex congenital heart disease. I have published across various areas of intensive care and have participated in national and international conferences, reflecting my commitment to clinical care, medical education, and research.

Dr. Mohammed Al-Hijji is a Senior Consultant in Interventional and Structural Cardiology at the Heart Hospital, Hamad Medical Corporation (HMC), Doha, Qatar, where he leads the Structural Heart Disease and Valve Programs. He also serves as Program Director of the Cardiology Fellowship and is an Assistant Professor of Medicine at Weill Cornell Medicine–Qatar.
Dr. Al-Hijji graduated with distinction from Weill Cornell Medical College in Qatar before completing Internal Medicine residency training at Johns Hopkins University. He subsequently pursued advanced cardiovascular training at Mayo Clinic, completing fellowships in Cardiovascular Diseases, Interventional Cardiology, and Advanced Structural and Interventional Cardiology. He is American Board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology, and Echocardiography.
His clinical practice focuses on complex coronary and structural heart interventions, including transcatheter aortic valve replacement (TAVR), mitral and tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, left atrial appendage occlusion, paravalvular leak closure, congenital heart interventions, and complex PCI.
Dr. Al-Hijji has played a leading role in expanding advanced structural heart therapies in Qatar and the region, introducing innovative procedures and developing Heart Hospital into a regional center for structural heart intervention, education, and training. His team has performed several regional and international first procedures, including pioneering transcatheter approaches for complex valvular and structural heart disease.
Alongside his clinical leadership, Dr. Al-Hijji is actively involved in cardiovascular research, innovation, medical education, and international scientific collaboration, with particular interests in structural heart disease, interventional cardiology, and artificial intelligence applications in cardiovascular medicine.

Dr Mohammad Amin is a Consultant Cardiologist / Cardiac Electrophysiologist and Head of Electrophysiology Department at Mohamed bin Khalifa Specialist Cardiac Centre in Bahrain. He is a graduate of University of British Columbia, Canada where he completed Cardiology and Clinical Cardiac Electrophysiology Fellowships. He is currently Board certified in Cardiac Electrophysiology and Cardiac Devices by the International Board of Heart Rhythm Examiners and a Fellow of Heart Rhythm Society.
His clinical practices focus on management of heart rhythm disorder both invasive and non-invasive along with electronic cardiac devices implantation and follow up. Since his return he is focusing on performing catheter ablation with near zero fluoroscopy, Catheter Ablation of Atrial fibrillation, and complex device implantation including Conductive System Pacing & Leadless Pacemaker Implant. He also established the Left Atrial Appendage Occlusion program in Bahrain, and he is an active member of the structural Heart intervention team performing percutaneous Mitral Valve repair, Trans catheter Mitral Valve implant, LAVA-ECMO etc.
His research interest is minimizing radiation exposure during catheter ablation of arrhythmia, and he is the principal investigator of AALARA study assessing impact of routine use 3-D mapping to perform Supra Ventricular Tachycardia Ablation with minimal fluoroscopic exposure. He has numerous publications in both General cardiology and Electrophysiology including being the local investigator of the INTERHEART study, QUADRA MP-ME Study, GULF-ACTION study, and PEACE-MENA study.

Dr. Al-Sayed graduated from Arabian Gulf University,
college of Medicine in Bahrain. She is American Board
Certified. She completed her Residency training in
Internal medicine at Sinai-Grace Hospital, Wayne State
University, Detroit, Michigan, USA and Fellowship
training in Endocrinology and Diabetes at Cleveland
Clinic Foundation, Ohio, USA. Dr. Al-Sayed is also
American Board Certified in Clinical Lipidology and a
fellow of American College of Physicians and fellow of
American College of Endocrinologists. She has worked
as assistant professor at Arabian Gulf University and is
currently at Gulf Medical & Diabetes Specialist Center in
Bahrain. Dr. Al-Sayed is a member of several
international Lipid, Diabetes and Endocrine associations.
She served as the President-Elect of the American
Association of Clinical Endocrinology Gulf Chapter and
as the Co-Founder and President of the Gulf Association
of Endocrinology and Diabetes. In the lipidology field,
she is a member of expert panel for Middle East Familial
Hypercholesterolemia guidelines and FH Gulf registry
and recently (January 2025) appointed as the Chair of
the Africa and Middle East Regional Federation of the
International Atherosclerosis Society.
Dr. Alsayed participated with an expert panel and
published the first consensus recommendation for
management of plasma lipid disorders for Middle East.
She has other several publications in the diabetes and
endocrine field. She is currently the owner/founder and
the Chief Medical Officer at the Dar Alsaha Medical
Center, Kingdom of Bahrain.

Professor Kreutz is a Full Professor of Clinical Pharmacology and Hypertensiology and the Director of the Department of Clinical Pharmacology and Toxicology at Charité – Universitätsmedizin Berlin, Germany. He is a Past President of the European Society of Hypertension (ESH).
He received the Franz Volhard Award of the German Society of Hypertension in 1992, the Young Investigator Award of the Dr. C & F. Demuth Foundation from the International Society of Hypertension (ISH) in 1996, and the Franz Gross Science Award of the German Society of Hypertension in 2021.
His main research interests include the clinical pharmacology of cardiovascular drugs and both clinical and experimental hypertension. He has been a member of the Scientific Council of the European Society of Hypertension (ESH) from 2015 t0 2026. Within the ESH, he served as Secretary from 2017 to 2019 and as President from 2019 to 2022. He was Co-Chair of the 2023 ESH Hypertension Guidelines Task Force and of the 2024 ESH Clinical Practice Guidelines for the Management of Hypertension.
Professor Kreutz was awarded honorary membership of the Polish Society of Hypertension in 2022 and the Hungarian Society of Hypertension in 2024. In 2022, he also received an honorary doctorate (honoris causa) from the School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece.

Dr. Rizwan Rehman is a Pediatric and Adult Congenital Interventional Cardiologist. Having studied at Birmingham University, United Kingdom, he completed his Pediatric Cardiology training between Birmingham Children's and Leicester Hospital. Dr Rizwan completed interventional fellowship training at the Institut Jantung Negara (Malaysia) and Okayama Hospital Japan. Subsequently he was appointed as Consultant Pediatric and Adult Congenital Interventional Cardiologist at Leicester Hospital UK prior to his appointment as a Consultant here at Sheikh Khalifa Medical City, Abu Dhabi.

Dr Rizwan Rehman has an interest in complex interventions. He was awarded the innovation prize in Leicester for his work developing the preterm PDA programme. More recently he has established the Percutaneous Pulmonary valve Programme within Abu Dhabi. He is an active member of the international community having previously served at the PICES (Pediatric Interventional Cardiology Early Career Society) as the international Rep and continues to participate in interventional meetings. 

Dr. Sadeer Al-Kindi received his MD from Weill Cornell Medical College in Qatar. He went on to complete his residency in internal medicine, fellowships in cardiovascular medicine and cardiovascular imaging at University Hospitals – Case Western Reserve University in Cleveland, Ohio. He then served as the co-director for the cardiometabolic center and a staff cardiologist at University Hospitals. In 2023, Dr Al-Kindi moved to Houston Methodist DeBakey Heart and Vascular Center.
Clinically, Dr. Al-Kindi serves as a preventive and an imaging cardiologist at the Houston Methodist DeBakey Heart and Vascular Center, where he is the associate director for the division of cardiovascular prevention and wellness and a member of the cardiovascular imaging faculty at Houston Methodist. Dr Al-Kindi uses advanced imaging to guide therapeutic interventions to reduce risk.

Graduated from the University of Auckland in New Zealand, completed a pediatric residency in Oman Medical Speciality Board, then I joined the local fellowship pediatric cardiology fellowship program at the National Heart Centre and am currently working as a pediatric cardiologist. I have a special interest in pediatric advanced heart failure and heart transplant.

Dr. Sonia Alsaidi serves as Professor and Head of Pediatric Cardiology; Director of Pediatric Cardiac Critical Care at Cairo University, Abu El-Rish University Hospital in Cairo, Egypt.

Dr. Steve R. Ommen is a cardiologist at Mayo Clinic whose specialties include hypertrophic cardiomyopathy and valvular heart disease. He directs Mayo Clinic’s Hypertrophic Cardiomyopathy Clinic and is active in clinical research and practice guidelines.

Dr. Tasneem Al Rashdi is an Adult Cardiology Consultant at the National Heart Center, Royal Hospital, Muscat, Sultanate of Oman. She provides clinical cardiology services, with specialized expertise in echocardiography and structural cardiac imaging. She completed her training in echocardiography and structural imaging at McMaster University, Canada. Her clinical interests include valvular heart disease, advanced echocardiographic assessment, and imaging guidance for structural heart interventions. Her practice encompasses transthoracic, transoesophageal, and three-dimensional echocardiography to support clinical decision making and procedural planning. She also contributes to medical education, multidisciplinary care, and quality improvement, with a particular focus on enhancing echocardiography services.

Dr. Tuqa is a highly accomplished paediatric cardiologist with specialised expertise in paediatric echocardiography, congenital heart disease, and advanced cardiac imaging including 3- Dimensional Echocardiography..She brings with her a wealth of clinical, academic, and leadership experience gained across leading institutions in Oman, Australia, and Canada.
Dr. Tuqa completed her Bachelor of Health Sciences and Doctor of Medicine from Sultan Qaboos University, Oman, followed by her Paediatric Residency through the Oman Medical Specialty Board. She subsequently pursued internationally recognised advanced training, completing a Fellowship in Paediatric Cardiology at The Royal Children’s Hospital, Melbourne, Australia, and a Fellowship in Paediatric Advanced Echocardiography at Stollery Children’s Hospital, University of Alberta, Canada. She holds the Membership of the Royal College of Paediatrics and Child Health, UK (MRCPCH), and a Specialty Certificate in Paediatrics from the Oman Medical Specialty Board.
Over the course of her career, Dr. Tuqa has built an outstanding clinical and leadership profile, serving as Consultant in Paediatric Cardiology, Chairperson of the Paediatric ECHO Lab, and Head of Quality at the National Heart Centre. Her areas of expertise include advanced two- and three-dimensional echocardiography, congenital heart disease assessment, and complex paediatric cardiac imaging.

Dr. Wael Al Qarawi serves as Assistant Professor; Consultant Cardiologist and Cardiac Electrophysiologist at King Saud University, Mouwasat Hospital Riyadh in Riyadh, Saudi Arabia.

Dr. Wouters Meijers serves as Post Doctoral Researcher at Vanderbilt University in Vanderbilt University, United States of America.

Dr. Ziyab Khan serves as Cardiac Surgeon; Structural Heart Specialist at Sultan Qaboos University Hospital in Muscat, Oman.